Fundraising Fox

Hyprevention

New York, US · Founded 2021 · Delaware corporation

Hyprevention develops STRUTPLASTY, a technology combining PEEK implantable devices with PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. The products are designed to treat fractures and help prevent new ones.

Founders & leadership

CV
Cecile VienneyNamed on SEC filing
BL
Brandford LuNamed on SEC filing
KL
Kathryn LarsonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$16.1M disclosed across 1 round · 2024

$16.1MraisedMay 2024 · 42 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Cecile VienneyDirector
  • Brandford LuDirector
  • Kathryn LarsonDirector
Offering amount
$16.1M
Amount sold
$16.1M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Hyprevention for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Hyprevention do?
Hyprevention develops STRUTPLASTY, a technology combining PEEK implantable devices with PMMA bone cement to reinforce bones weakened by osteoporosis or cancer. The products are designed to treat fractures and help prevent new ones.
How much funding has Hyprevention raised?
Hyprevention has disclosed $16.1M raised across 1 round.
Where is Hyprevention headquartered?
Hyprevention is headquartered in New York, US.